XLVvsIHIETF Comparison
VS
State Street Health Care Select Sector SPDR ETF (XLV) and iShares U.S. Medical Devices ETF (IHI) belong to the same industry segment: US Health Care. XLV's top 2 sector exposures are Healthcare and Consumer Non-Cyclicals. In contrast, IHI's top sector exposures are Healthcare, Non-Corporate and Finance. XLV is less expensive with a Total Expense Ratio (TER) of 0.08%, versus 0.37% for IHI. XLV is up 11.74% year-to-date (YTD) with +$583M in YTD flows. IHI performs worse with -13.48% YTD performance, and -$129M in YTD flows. Run a side-by-side ETF comparison of XLV and IHI below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
XLV vs IHI performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/04/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XLV IHI | +5.84%-0.83% | +13.31%+7.72% | +11.74%-13.48% | +26.92%-13.04% | +36.33%+5.59% | +36.64%-17.92% |
| Flows | XLV IHI | +$374M+$60M | +$699M+$122M | +$583M-$129M | +$2.02B-$407M | -$5.34B-$2.53B | +$1.95B-$3.75B |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XLV IHI | +18.82%+25.73% | +16.03%+20.17% | +14.66%+18.30% | +15.15%+19.75% |
| Max drawdown | XLV IHI | -3.83%-5.85% | -10.51%-26.18% | -17.05%-26.72% | -17.05%-33.07% |
| Max drawdown duration | XLV IHI | 20d20d | 116d283d | 444d576d | 444d1822d |
Trading data
XLV | IHI | |
Last sale 9/8/2026 at 2:31 PM | $167.82 | $52.27 |
| Previous close 09/04/2026 | $171.45 | $53.63 |
| Consolidated volume 09/04/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
XLV | IHI | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/8/2026 at 2:31 PM
Live
Closed
XLV | IHI | |
|---|---|---|
| Last price | $167.82 | $52.27 |
| 1D performance | -2.12% | -2.54% |
| AuM | $44.50 B | $3.38 B |
| E/R | 0.08% | 0.37% |
Characteristics
XLV | IHI | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | State Street Investment Management | iShares |
| Benchmark | S&P Health Care Select Sector Index | Dow Jones U.S. Select Medical Equipment Index |
| N° of holdings | 59 | 47 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 1998 | May 1, 2006 |
| ESG | No | No |
Advertisement
Exposure
Countries
XLV
USA
97.53%
Other
2.47%
IHI
USA
91.29%
Ireland
7.82%
Other
0.88%
Sectors
XLV
Healthcare
97.51%
Other
2.49%
IHI
Healthcare
99.85%
Other
0.15%
Advertisement
Diversification
XLV
Total weight of top 15 holdings out of 15
71.77%
IHI
Total weight of top 15 holdings out of 15
87.99%
Top 15 holdings
Data as of July 31, 2026
XLV
Eli Lilly & Co.
15.48%
Johnson & Johnson
10.51%
AbbVie, Inc.
7.55%
UnitedHealth Group, Inc.
6.41%
Merck & Co., Inc.
5.48%
Thermo Fisher Scientific, Inc.
3.64%
Amgen, Inc.
3.54%
Abbott Laboratories
3.14%
Gilead Sciences, Inc.
2.75%
Pfizer Inc.
2.43%
Bristol Myers Squibb Co.
2.27%
CVS Health Corp.
2.27%
Intuitive Surgical, Inc.
2.13%
Danaher Corp.
2.09%
Vertex Pharmaceuticals, Inc.
2.06%
IHI
Abbott Laboratories
18.49%
Intuitive Surgical, Inc.
12.57%
Stryker Corp.
12.07%
Becton, Dickinson & Co.
4.75%
GE Healthcare Technologies, Inc.
4.62%
Medtronic Plc
4.53%
ResMed, Inc.
4.40%
Edwards Lifesciences Corp.
4.29%
IDEXX Laboratories, Inc.
4.25%
DexCom, Inc.
4.18%
Boston Scientific Corp.
4.03%
STERIS Plc (Ireland)
3.30%
Zimmer Biomet Holdings, Inc.
2.67%
Baxter International, Inc.
2.01%
Penumbra, Inc.
1.83%
Frequently asked questions about XLV and IHI
How have the XLV and IHI ETFs performed in 2026?
As of September 4, 2026, XLV is up 11.74% year-to-date (YTD), while IHI has lost -13.48%. That puts XLV better performer ahead so far this year.
Which ETF is attracting more investor money: XLV or IHI?
Year-to-date, the XLV ETF saw +$583M in flows, compared to -$129M for IHI.
Which ETF is more volatile: XLV or IHI?
Over the past year, XLV had a volatility of 16.03%, while IHI experienced 20.17%.
Which ETF is bigger: XLV or IHI?
As of September 4, 2026, XLV holds $44.50 B in assets under management (AUM), while IHI manages $3.38 B.
What sectors do the XLV and IHI ETFs invest in?
XLV leans toward sectors like Healthcare. Meanwhile, IHI focuses on Healthcare.
What are the top holdings of the XLV ETF and IHI ETF?
XLV top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. IHI holds in its top three: Abbott Laboratories, Intuitive Surgical, Inc. and Stryker Corp..
Which ETF is more diversified: XLV or IHI?
XLV holds 59 securities with 71.77% of its assets in the top 15. IHI has 47 securities and a top 15 weight of 87.99%.
Advertisement
Latest news about XLV & IHI
ETF Model Portfolios: The Cockroach Portfolio
March 20, 2026
XLV
ETF Central's Guide to Defensive Sector Investing
March 13, 2026
XLV
Chinese Artificial Intelligence (AI) DeepSeek: ETF Winners & Losers
January 27, 2025
XLV
Investing in Sector ETFs: Consumer Staples, Healthcare, & Utilities
August 21, 2024
XLV
Advertisement
Notable ETF Filings Recap: April 2024
May 2, 2024
IHI
Notable ETF Filings Recap: April 2024
May 2, 2024
IHI
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
XLV
Advertisement
